病院前蘇生試験中のO型全血と年齢の評価 (TOWAR)
入院前蘇生(TOWAR)試験中のO型全血と年齢の評価
Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to component blood resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize the hemostatic competency of whole blood relative to its age.
調査の概要
研究の種類
入学 (実際)
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35294
- University of Alabama at Birmingham
-
-
Kentucky
-
Louisville、Kentucky、アメリカ、40292
- University of Louisville
-
-
Mississippi
-
Jackson、Mississippi、アメリカ、39216
- University of Mississippi Medical Center (UMMC)
-
-
Ohio
-
Cincinnati、Ohio、アメリカ、45267
- University of Cincinatti
-
Cleveland、Ohio、アメリカ、44109
- Metrohealth Systems
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15213
- University of Pittsburgh
-
-
Tennessee
-
Knoxville、Tennessee、アメリカ、37920
- University of Tennessee Medical Center
-
Nashville、Tennessee、アメリカ、37232
- Vanderbilt University Medical Center
-
-
Texas
-
Houston、Texas、アメリカ、77030
- University of Texas Health Science Center at Houston
-
-
Washington
-
Seattle、Washington、アメリカ、98104
- University of Washington
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
1.) Injured patients at risk of hemorrhagic shock being transported from scene or referral hospital to a participating TOWAR trial site that meet requirements for initiation of blood or blood component transfusion
AND
2A.) Systolic blood pressure ≤ 90mmHg and tachycardia (HR ≥ 108) at scene, at outside hospital or during transport OR
2B.) Systolic blood pressure ≤ 70mmHg at scene, at outside hospital or during transport
Exclusion Criteria:
- Wearing NO TOWAR opt-out bracelet
- Age > 90 or < 18 years of age
- Isolated fall from standing injury mechanism
- Known prisoner or known pregnancy
- Traumatic arrest with > 5 minutes of CPR without return of vital signs
- Brain matter exposed or penetrating brain injury (GSW)
- Isolated drowning or hanging victims
- Objection to study voiced by subject or family member at the scene
- Inability to obtain IV or intraosseous access
- Isolated burns without evidence of traumatic injury
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Whole Blood
Subjects will receive up to two units of whole blood as collected by local blood bank procedures and stored at 1-6 degrees Celsius initiated in the prehospital phase of care. |
low titer whole blood, group O kept to either 21 days or 35 days based upon which preservation process is employed at each respective participating site |
|
アクティブコンパレータ:Component transfusion
Subjects will receive prehospital crystalloid infusion or blood component transfusion resuscitation per site standard care for the respective Emergency Medical unit/service. |
crystalloid infusion or blood component transfusion resuscitation |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
30 Day Mortality
時間枠:thru 30 days of enrollment
|
All cause mortality within 30 days |
thru 30 days of enrollment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
3-hour Mortality
時間枠:Enrollment through 3 hours
|
Death within 3 hours of enrollment |
Enrollment through 3 hours
|
|
6-hour Mortality
時間枠:Enrollment through 6 hours
|
Death within 6 hours of enrollment |
Enrollment through 6 hours
|
|
24-hour Mortality
時間枠:Enrollment through 24 hours
|
Death within 24 hours of enrollment |
Enrollment through 24 hours
|
|
In-hospital Mortality
時間枠:Enrollment through hospital discharge or 30 days
|
Death prior to hospital discharge |
Enrollment through hospital discharge or 30 days
|
|
Blood and Blood Component Transfusion Amount
時間枠:Enrollment through 24 hours
|
Number of units of blood or blood component transfused |
Enrollment through 24 hours
|
|
Multiple Organ Failure (MOF)
時間枠:Enrollment through 7 days or ICU discharge
|
Organ dysfunction will be evaluated via the Denver Post-injury Multiple Organ Failure Score. Patients who are never admitted to the Intensive Care Unit (ICU) or those with a length of ICU stay of less than 48 hours will be considered to have a Denver score of 0. A summary of the Denver score may be calculated by summing the worst scores of each of the individual systems over the course of the ICU stay. A summary Denver score > 3 will be classified as MOF. |
Enrollment through 7 days or ICU discharge
|
|
Hospital-acquired Pneumonia
時間枠:Number of participants who develop pneumonia through 30 days
|
Pneumonia acquired during hospitalization per Center for Disease Control (CDC) criteria |
Number of participants who develop pneumonia through 30 days
|
|
Blood Stream Infection
時間枠:Number of participants who develop blood stream infection through 30 days
|
Blood stream infection during hospitalization per CDC criteria |
Number of participants who develop blood stream infection through 30 days
|
|
Acute Respiratory Distress Syndrome (ARDS)
時間枠:Number of participants who develop ARDS through 30 days
|
The Berlin definition for mild ARDS (PaO2/FIO2, ≤ 300 mm Hg + timing, imaging and origin criteria) will be utilized as a threshold value to determine the incidence of ARDS and will be further stratified into Moderate (PaO2/FIO2, ≤ 200 mm Hg) and Severe (PaO2/FIO2, ≤ 100 mm Hg). |
Number of participants who develop ARDS through 30 days
|
|
Abnormal International Normalized Ratio (INR)
時間枠:Enrollment through 60 minutes
|
Measurement of platelet hemostatic function |
Enrollment through 60 minutes
|
|
Achievement of Hemostasis
時間枠:Enrollment through 4 hours
|
Ability to reach nadir transfusion requirement of 1 unit of red blood cells in a 60-minute time period in the first 4 hours following arrival |
Enrollment through 4 hours
|
|
Transfusion Reaction
時間枠:Enrollment through 24 hours
|
Any transfusion complication |
Enrollment through 24 hours
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Jason L Sperry, MD、University of Pittsburgh
出版物と役立つリンク
一般刊行物
- Brunskill SJ, Disegna A, Wong H, Fabes J, Desborough MJ, Doree C, Davenport R, Curry N, Stanworth SJ. Blood transfusion strategies for major bleeding in trauma. Cochrane Database Syst Rev. 2025 Apr 24;4(4):CD012635. doi: 10.1002/14651858.CD012635.pub2.
- Meizoso JP, Cotton BA, Lawless RA, Kodadek LM, Lynde JM, Russell N, Gaspich J, Maung A, Anderson C, Reynolds JM, Haines KL, Kasotakis G, Freeman JJ. Whole blood resuscitation for injured patients requiring transfusion: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2024 Sep 1;97(3):460-470. doi: 10.1097/TA.0000000000004327. Epub 2024 Mar 27.
- Sperry JL, Guyette FX, Cotton BA, Luther JF, Utarnachitt RB, Kutcher ME, Daley BJ, Peetz AB, Patel MB, Goodman MD, Claridge JA, Patel N, Harbrecht BG, Hashmi ZG, Zarychanski R, Neal MD, Yazer MH, Martin-Gill C, Vincent LE, Harner AM, Meyer DE, Latimer AJ, Robinson BR, McKnight CL, Hinckley WR, Miller KR, Jansen JO, Martin D, Fox EE, Rosario-Rivera BL, Wisniewski SR; TOWAR Study Group. Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage. N Engl J Med. 2026 Jun 18;394(23):2317-2328. doi: 10.1056/NEJMoa2602167. Epub 2026 May 18.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- STUDY20110430
- W81XWH-16-D-0024 (その他の助成金/資金番号:Department of Defense)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
De-identified data may be shared with the funding agency as well as other researchers upon request to the Principal Investigator.
IPD 共有時間枠
Data will become available after publication of the primary manuscript.
IPD 共有アクセス基準
Requests for data will be submitted in writing and reviewed by the Principal Investigator.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。